HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pål Aukrust Selected Research

Carotid Artery Diseases

12/2020N6-methyladenosine in RNA of atherosclerotic plaques: An epitranscriptomic signature of human carotid atherosclerosis.
10/2020Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis.
1/2020Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages.
1/2017Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation.
4/2016The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
1/2016Enhanced base excision repair capacity in carotid atherosclerosis may protect nuclear DNA but not mitochondrial DNA.
3/2015Interleukin 23 levels are increased in carotid atherosclerosis: possible role for the interleukin 23/interleukin 17 axis.
4/2014Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells.
1/2014Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis.
1/2013Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pål Aukrust Research Topics

Disease

155Inflammation (Inflammations)
11/2022 - 02/2002
83Heart Failure
04/2022 - 01/2001
73Atherosclerosis
01/2022 - 04/2002
50Myocardial Infarction
05/2021 - 03/2004
34Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 07/2002
29Acute Coronary Syndrome
10/2021 - 07/2002
28Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 04/2002
28Atherosclerotic Plaque (Atheroma)
10/2021 - 07/2002
23Infections
10/2022 - 03/2003
19Fibrosis (Cirrhosis)
11/2022 - 03/2003
15Common Variable Immunodeficiency
10/2022 - 06/2003
15ST Elevation Myocardial Infarction
06/2022 - 05/2009
14Schizophrenia (Dementia Praecox)
01/2022 - 11/2009
14Insulin Resistance
12/2020 - 06/2006
14Necrosis
12/2020 - 01/2001
13Carotid Artery Diseases
12/2020 - 08/2010
13Stroke (Strokes)
06/2020 - 06/2008
13HIV Infections (HIV Infection)
02/2020 - 04/2003
11Type 2 Diabetes Mellitus (MODY)
11/2022 - 07/2012
11Pneumonia (Pneumonitis)
10/2022 - 01/2016
11Chronic Obstructive Pulmonary Disease (COPD)
12/2021 - 02/2010
11Infarction (Infarctions)
01/2021 - 03/2004
10Obesity
04/2022 - 09/2009
10Mental Disorders (Mental Disorder)
01/2022 - 11/2009
10Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2021 - 01/2003
9COVID-19
05/2022 - 10/2020
9Aortic Valve Stenosis (Aortic Stenosis)
01/2021 - 08/2011
9Neoplasms (Cancer)
01/2020 - 11/2004
9Hypoxia (Hypoxemia)
01/2019 - 04/2009
8Thrombosis (Thrombus)
05/2022 - 08/2004
8Venous Thromboembolism
04/2022 - 12/2018
8Non-ST Elevated Myocardial Infarction
01/2021 - 08/2016
8Bipolar Disorder (Manic Depressive Psychosis)
01/2020 - 11/2009
8Disease Progression
01/2018 - 04/2003
7Respiratory Insufficiency (Respiratory Failure)
05/2022 - 10/2020
7Hypertrophy
04/2021 - 03/2003
7Pulmonary Hypertension
01/2019 - 08/2004
7Ventricular Remodeling
01/2019 - 07/2005
7Ischemic Stroke
12/2018 - 07/2006
6Dyslipidemias (Dyslipidemia)
01/2022 - 07/2011
6Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 04/2013
6Malaria
10/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

72CytokinesIBA
04/2022 - 01/2001
51Biomarkers (Surrogate Marker)IBA
11/2022 - 02/2007
41C-Reactive ProteinIBA
12/2021 - 04/2004
36ChemokinesIBA
01/2021 - 04/2002
32Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2002
29Interleukin-6 (Interleukin 6)IBA
06/2022 - 04/2002
29LipidsIBA
01/2022 - 04/2004
26Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2001
25Messenger RNA (mRNA)IBA
01/2021 - 07/2002
23LigandsIBA
01/2022 - 10/2003
22Glucose (Dextrose)FDA LinkGeneric
11/2022 - 06/2008
22Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2020 - 01/2003
22OsteoprotegerinIBA
08/2019 - 11/2004
21Troponin T (Troponin T1)IBA
06/2022 - 11/2009
20EnzymesIBA
12/2020 - 04/2004
18InterleukinsIBA
06/2022 - 06/2003
18InflammasomesIBA
01/2022 - 07/2013
18Complement System Proteins (Complement)IBA
02/2021 - 01/2002
16CholesterolIBA
01/2022 - 09/2009
16Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 03/2004
15Rosuvastatin Calcium (Crestor)FDA Link
11/2019 - 03/2011
15CD40 Ligand (CD40L)IBA
02/2015 - 01/2003
13pro-brain natriuretic peptide (1-76)IBA
01/2022 - 08/2011
13Interleukin-8 (Interleukin 8)IBA
12/2015 - 07/2002
12tocilizumab (atlizumab)FDA Link
06/2022 - 08/2016
12von Willebrand FactorIBA
12/2021 - 08/2005
11Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
10/2018 - 08/2009
10Interleukin-10 (Interleukin 10)IBA
01/2016 - 03/2003
9Interleukin-18 (Interleukin 18)IBA
01/2022 - 10/2003
9Apolipoproteins E (ApoE)IBA
10/2021 - 04/2006
9Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2021 - 08/2016
9Insulin (Novolin)FDA Link
01/2021 - 01/2010
9Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
10/2019 - 04/2003
9Toll-Like Receptors (Toll-Like Receptor)IBA
08/2015 - 07/2004
9activin AIBA
01/2015 - 03/2004
8Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 07/2011
8InterferonsIBA
11/2021 - 05/2010
8Immunoglobulins (Immunoglobulin)IBA
01/2021 - 04/2005
8LDL Lipoproteins (beta Lipoproteins)IBA
10/2020 - 10/2011
8LDL CholesterolIBA
10/2020 - 01/2014
8oxidized low density lipoproteinIBA
11/2019 - 11/2005
8Triglycerides (Triacylglycerol)IBA
06/2017 - 01/2011
8Matrix Metalloproteinases (MMPs)IBA
01/2014 - 05/2005
8Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2014 - 07/2002
7Trinitrotoluene (TNT)IBA
06/2022 - 06/2011
7Ferritins (Ferritin)IBA
05/2022 - 01/2018
7Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2022 - 08/2009
7AdipokinesIBA
01/2019 - 06/2006
7Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2016 - 11/2009
7RANK LigandIBA
06/2010 - 05/2005
6RNA (Ribonucleic Acid)IBA
06/2022 - 11/2015
6LeptinIBA
04/2022 - 06/2006
6IronIBA
04/2022 - 01/2018
6Interleukin-1 (Interleukin 1)IBA
01/2022 - 04/2004
6DNA Glycosylases (DNA Glycosylase)IBA
10/2021 - 06/2005
6trimethyloxamine (trimethylamine N-oxide)IBA
08/2021 - 02/2016

Therapy/Procedure

34Therapeutics
01/2022 - 01/2003
11Percutaneous Coronary Intervention
04/2021 - 08/2005